EnBio Holdings, Inc (TYO:6092)
Japan
· Delayed Price · Currency is JPY 572.00
-2.00 (-0.35%)
Apr 25, 2025, 3:30 PM JST
EnBio Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3,379 | 3,604 | 2,828 | 2,371 | 2,015 | 2,981 | Upgrade
|
| Cash & Short-Term Investments | 3,379 | 3,604 | 2,828 | 2,371 | 2,015 | 2,981 | Upgrade
|
| Cash Growth | 4.21% | 27.44% | 19.28% | 17.67% | -32.41% | 27.34% | Upgrade
|
| Receivables | 2,403 | 1,270 | 792 | 1,593 | 948 | 1,330 | Upgrade
|
| Inventory | 2,725 | 2,889 | 3,373 | 1,849 | 3,119 | 2,448 | Upgrade
|
| Other Current Assets | 308.34 | 483 | 325 | 645 | 533 | 820 | Upgrade
|
| Total Current Assets | 8,815 | 8,246 | 7,318 | 6,458 | 6,615 | 7,579 | Upgrade
|
| Property, Plant & Equipment | 8,693 | 7,918 | 7,016 | 7,914 | 7,332 | 5,746 | Upgrade
|
| Long-Term Investments | 2,882 | 1,375 | 1,186 | 1,221 | 1,012 | 1,083 | Upgrade
|
| Goodwill | 96.07 | 102 | 110 | 118 | 126 | 134 | Upgrade
|
| Other Intangible Assets | 357.34 | 373 | 399 | 427 | 454 | 481 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 2 | 8 | Upgrade
|
| Other Long-Term Assets | 0.01 | 1 | 1 | 2 | 2 | 3 | Upgrade
|
| Total Assets | 20,843 | 19,310 | 17,349 | 16,370 | 15,698 | 15,034 | Upgrade
|
| Accounts Payable | 848.7 | 1,098 | 485 | 693 | 595 | 757 | Upgrade
|
| Accrued Expenses | 23.89 | 36 | 31 | 50 | - | - | Upgrade
|
| Short-Term Debt | 2,764 | 1,088 | 854 | 645 | 955 | 1,493 | Upgrade
|
| Current Portion of Long-Term Debt | 1,279 | 1,300 | 2,293 | 1,276 | 1,050 | 1,425 | Upgrade
|
| Current Income Taxes Payable | 193.11 | 183 | 316 | 315 | 20 | 284 | Upgrade
|
| Other Current Liabilities | 65.94 | 439 | 492 | 467 | 408 | 634 | Upgrade
|
| Total Current Liabilities | 5,442 | 4,144 | 4,471 | 3,446 | 3,028 | 4,593 | Upgrade
|
| Long-Term Debt | 5,926 | 6,230 | 5,749 | 6,660 | 7,030 | 5,184 | Upgrade
|
| Other Long-Term Liabilities | 495.54 | 347 | 273 | 290 | 323 | 366 | Upgrade
|
| Total Liabilities | 11,863 | 10,721 | 10,493 | 10,396 | 10,381 | 10,143 | Upgrade
|
| Common Stock | 2,325 | 2,325 | 1,797 | 1,797 | 1,794 | 1,786 | Upgrade
|
| Additional Paid-In Capital | 2,405 | 2,405 | 1,876 | 1,876 | 1,873 | 1,865 | Upgrade
|
| Retained Earnings | 4,262 | 3,761 | 3,111 | 2,352 | 1,743 | 1,439 | Upgrade
|
| Treasury Stock | -50.41 | -15 | -15 | -15 | - | - | Upgrade
|
| Comprehensive Income & Other | -50.71 | 17 | 18 | -121 | -123 | -204 | Upgrade
|
| Total Common Equity | 8,892 | 8,493 | 6,787 | 5,889 | 5,287 | 4,886 | Upgrade
|
| Minority Interest | 88.25 | 96 | 69 | 85 | 30 | 5 | Upgrade
|
| Shareholders' Equity | 8,980 | 8,589 | 6,856 | 5,974 | 5,317 | 4,891 | Upgrade
|
| Total Liabilities & Equity | 20,843 | 19,310 | 17,349 | 16,370 | 15,698 | 15,034 | Upgrade
|
| Total Debt | 9,969 | 8,618 | 8,896 | 8,581 | 9,035 | 8,102 | Upgrade
|
| Net Cash (Debt) | -6,589 | -5,014 | -6,068 | -6,210 | -7,020 | -5,121 | Upgrade
|
| Net Cash Per Share | -815.35 | -628.52 | -913.63 | -934.94 | -1056.54 | -771.24 | Upgrade
|
| Filing Date Shares Outstanding | 8.08 | 8.14 | 8.14 | 6.64 | 6.59 | 6.57 | Upgrade
|
| Total Common Shares Outstanding | 8.08 | 8.14 | 6.64 | 6.64 | 6.65 | 6.57 | Upgrade
|
| Working Capital | 3,373 | 4,102 | 2,847 | 3,012 | 3,587 | 2,986 | Upgrade
|
| Book Value Per Share | 1100.22 | 1043.71 | 1022.55 | 886.25 | 795.33 | 743.56 | Upgrade
|
| Tangible Book Value | 8,438 | 8,018 | 6,278 | 5,344 | 4,707 | 4,271 | Upgrade
|
| Tangible Book Value Per Share | 1044.12 | 985.33 | 945.86 | 804.23 | 708.08 | 649.96 | Upgrade
|
| Order Backlog | - | 3,624 | 2,912 | 1,514 | 2,633 | 1,827 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.